Elliot C. Mendelson founded Mendelson IP in 2009. His practice focuses on opinions and counseling, due diligence, patent prosecution, and intellectual property litigation. He also serves as local counsel for out of state attorneys with cases pending before the District Court of Delaware.
Over the course of his career, Dr. Mendelson has been involved in ANDA, infringement, and inventorship litigations related to some of the most important pharmaceutical and biological products on the market today. He has also managed the FTO work for one of the largest and most historic collaborations between a pharmaceutical company and a biotech company.
Dr. Mendelson's technical focus has an emphasis in the areas of pharmaceuticals and biotechnology including: Small Molecules, Antibodies, Biologics, Blood Products, Drug Discovery, Gene Therapy, Modified Crops, Separation/Purification processes, and Vaccines.
Dr. Mendelson was previously an attorney at the Chicago firms Rokoczy Molino Mazzochi Siwik LLP and Marshall Gerstein & Borun LLP. Before that, Dr. Mendelson was an associate at the law firm of Connolly Bove Lodge & Hutz LLP in Wilmington.
Dr. Mendelson received his J.D. from Georgetown University Law Center. While attending law school, he worked full-time as a Law Clerk/Patent Agent at Howrey & Simon.
Immediately prior to entering the legal profession, Dr. Mendelson worked as a Clinical Research Specialist drafting Investigational New Drug Applications (INDs) for the Regulatory Affairs Branch of the National Cancer Institute.
Dr. Mendelson received his B.S. in Biology from S.U.N.Y at Binghamton. He went on to receive his Ph.D. in Microbiology from the University of Virginia, where his research focused on mechanisms of viral assembly.
Following his doctorate at the University of Virginia, Dr. Mendelson went on to two postdoctoral positions; first as a Postdoctoral Research Associate at Purdue University Cancer Center and then as a Postdoctoral Fellow at the Georgetown University School of Medicine.